I track what is happening with employer health plans carefully because they cover almost half of all Americans and they are often leading indicators for health benefit trends and cost trends. This survey comes from Mercer, a large consulting firm. As Mercer states, employers are walking a fine line between trying to keep benefit costs under control, provide good benefits, and not shift costs too much to lower-wage workers. Costs per employee rose 5.2% in 2023 to $15,800 and employers are expecting another large increase in 2024. Cost increases at 7.8% and per employee costs at $16,500 were higher for small employers. Drugs, particularly specialty drugs were the biggest contributor to cost increases, with spending rising 8.4% in this category. Large employers are using specialized care networks, second opinions and more intensive care management to try to limit health spending rises. I think these strategies will have little impact in the face of providers’ demands for higher reimbursement. (Mercer Survey)
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Cano Health apparently cannot, as it declares bankruptcy due to too much debt. Building primary care centers to serve Medicare, Medicaid and commercial populations, which is Cano’s business, was hot...
February 6, 2024
Turquoise health raises a fresh $30 million in capital for its price transparency platform, as the market for funding health care companies isn’t quite dead yet.
January 24, 2024
I am co-f0under of a company that manages cell and gene therapy for health plans. Cell therapy has made a big difference for many cancer patients but like all new...
January 24, 2024
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace